Acadia appoints elizabeth h. z. thompson, ph.d.

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced the appointment of dr. elizabeth h. z. thompson as executive vice president, head of research and development. dr. thompson will lead research and development at acadia and serve as a member of the company's executive leadership team, reporting to steve davis, chief executive officer of acadia. “liz is a preeminent drug research and development leader with extensive experience in the advancement and commercia.
ACAD Ratings Summary
ACAD Quant Ranking